Motohiro Kato

The University of Tokyo

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

SciProfiles

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Research Subjects

Research Interests

Motohiro Kato has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:

Daisuke Tomizawa
Division of Leukemia and Lymphoma, Children's Cancer Center National Center for Child Health and Development Tokyo Japan
105 shared publications
Junko Takita
Department of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan
93 shared publications
Takao Deguchi
Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan
85 shared publications
Masatoshi Takagi
Department of Pediatrics and Developmental Biology Institute of Science Tokyo Tokyo Japan
81 shared publications
Jun J. Yang
Department of Pharmacy and Pharmaceutical Sciences St. Jude Children's Research Hospital Memphis Tennessee USA
80 shared publications
Atsushi Manabe
Department of Pediatrics Hokkaido University Graduate School of Medicine Sapporo Japan
78 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 28 October 2026
- Published by Wiley in Pediatric Blood & Cancer
Haploidentical Hematopoietic Cell Transplantation for Infants With X‐Linked Severe Combined Immunodeficiency Using Post‐Transplant Cyclophosphamide
by Shuhei Takahashi, Akito Kawachi, Dan Tomomasa, Eri Watanabe, Yuji Fujita, Yuya Sato, Masahiro Sekiguchi, Kentaro Watanabe, Moe Hidaka, Akihiro Hoshino, et al.
Website
Google Scholar
- 28 October 2026
- Published by Wiley in Pediatric Blood & Cancer
Open Access
Haploidentical Hematopoietic Cell Transplantation for Infants With X‐Linked Severe Combined Immunodeficiency Using Post‐Transplant Cyclophosphamide
by Shuhei Takahashi, Akito Kawachi, Dan Tomomasa, Eri Watanabe, Yuji Fujita, Yuya Sato, Masahiro Sekiguchi, Kentaro Watanabe, Moe Hidaka, Akihiro Hoshino, et al.
Website
Google Scholar
- 15 October 2026
- Published by Wiley in Pediatric Blood & Cancer
Successful Salvage Therapy With Quizartinib Plus Chemotherapy Followed by Quizartinib Monotherapy for Transplant Bridging and Post‐Transplant Maintenance in a Child With Induction‐Refractory FLT3 ‐ITD‐Positive AML
by Keiji Tasaka, Koji Kawaguchi, Taemi Ogura, Hiroyuki Kuroda, Ryo Akazawa, Takayuki Takachi, Shota Kato, Masahiro Sekiguchi, Motohiro Kato, Kenichiro Watanabe
Website
Google Scholar
- 15 October 2026
- Published by Wiley in Pediatric Blood & Cancer
Successful Salvage Therapy With Quizartinib Plus Chemotherapy Followed by Quizartinib Monotherapy for Transplant Bridging and Post‐Transplant Maintenance in a Child With Induction‐Refractory FLT3 ‐ITD‐Positive AML
by Keiji Tasaka, Koji Kawaguchi, Taemi Ogura, Hiroyuki Kuroda, Ryo Akazawa, Takayuki Takachi, Shota Kato, Masahiro Sekiguchi, Motohiro Kato, Kenichiro Watanabe
Website
Google Scholar
- 27 July 2026
- Published by Springer Nature in Leukemia
Revisiting classical genetic subtypes reveals subtype-specific relapse patterns and MRD prognostic relevance in pediatric acute lymphoblastic leukemia
by Yasuo Kubota, Yasuhiro Okamoto, Toshihiko Imamura, Akiko Kada, Akiko M. Saito, Yuka Iijima-Yamashita, Masashi Sanada, Tomohiko Taki, Katsuyoshi Koh, Motohiro Kato
Website
Google Scholar
- 27 July 2026
- Published by Springer Nature in Leukemia
Revisiting classical genetic subtypes reveals subtype-specific relapse patterns and MRD prognostic relevance in pediatric acute lymphoblastic leukemia
by Yasuo Kubota, Yasuhiro Okamoto, Toshihiko Imamura, Akiko Kada, Akiko M. Saito, Yuka Iijima-Yamashita, Masashi Sanada, Tomohiko Taki, Katsuyoshi Koh, Motohiro Kato
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
A multi-national consortium of γδ T-ALL study.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S1 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
A multi-national consortium of γδ T-ALL study.
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S16 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
Differentially expressed genes (adjusted P <0.01 ) between PF382-STAG2KO and PF382-WT.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S16 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
Differentially expressed genes (adjusted P <0.01 ) between PF382-STAG2KO and PF382-WT.
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
Comparison of clinical characteristics and outcomes between gamma delta T-ALL and non-gamma delta T-ALL.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
Comparison of clinical characteristics and outcomes between gamma delta T-ALL and non-gamma delta T-ALL.
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
The genomic features of “Chromosome gains” and “TLX3” subtypes.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S4 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
The genomic features of “Chromosome gains” and “TLX3” subtypes.
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
The gene expression profiles of γδ T-ALL.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
The gene expression profiles of γδ T-ALL.
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S21 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
Compounds used in single-dose (10uM) drug screening.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S21 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
Compounds used in single-dose (10uM) drug screening.
Open Access
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S12 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
Differentially expressed genes (adjusted P <0.01 ) in STAG2/LMO2 subtype compared to other T-ALL cases.
Website
Google Scholar
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S12 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
by Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, Ilaria Iacobucci, Petri Pölönen, Qingsong Gao, Elizabeth D. Arnold, Andishe Attarbaschi, Anthony Brown, Barbara Buldini, et al.
Differentially expressed genes (adjusted P <0.01 ) in STAG2/LMO2 subtype compared to other T-ALL cases.

Show all

Motohiro Kato

Current Organizations / Institutes

Previous Organizations / Institutes

Research Subjects

Research Interests

Motohiro Kato has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:

Latest Publications

Haploidentical Hematopoietic Cell Transplantation for Infants With X‐Linked Severe Combined Immunodeficiency Using Post‐Transplant Cyclophosphamide

Haploidentical Hematopoietic Cell Transplantation for Infants With X‐Linked Severe Combined Immunodeficiency Using Post‐Transplant Cyclophosphamide

Successful Salvage Therapy With Quizartinib Plus Chemotherapy Followed by Quizartinib Monotherapy for Transplant Bridging and Post‐Transplant Maintenance in a Child With Induction‐Refractory FLT3 ‐ITD‐Positive AML

Successful Salvage Therapy With Quizartinib Plus Chemotherapy Followed by Quizartinib Monotherapy for Transplant Bridging and Post‐Transplant Maintenance in a Child With Induction‐Refractory FLT3 ‐ITD‐Positive AML

Revisiting classical genetic subtypes reveals subtype-specific relapse patterns and MRD prognostic relevance in pediatric acute lymphoblastic leukemia

Revisiting classical genetic subtypes reveals subtype-specific relapse patterns and MRD prognostic relevance in pediatric acute lymphoblastic leukemia

Supplementary Table S1 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S1 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S16 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S16 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Figure S4 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Figure S4 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Figure S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Figure S2 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S21 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S21 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S12 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

Supplementary Table S12 from Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk